Active Ingredient: BOSENTAN
Proprietary Name: BOSENTAN
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 62.5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A205173
Product Number: 001
Approval Date: Jan 15, 2020
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Discontinued
Patent and Exclusivity Information
